Meniscus degeneration due to age or injury can lead to osteoarthritis. Although promising, current cellbased approaches show limited success. Here we present three-dimensional methacrylated gelatin (GelMA) scaffolds patterned via projection stereolithography to emulate the circumferential alignment of cells in native meniscus tissue. Cultured human avascular zone meniscus cells from normal meniscus were seeded on the scaffolds. Cell viability was monitored, and new tissue formation was assessed by gene expression analysis and histology after 2 weeks in serum-free culture with transforming growth factor b1 (10 ng ml À1 ). Light, confocal and scanning electron microscopy were used to observe cell-GelMA interactions. Tensile mechanical testing was performed on unseeded, fresh scaffolds and 2-week-old cell-seeded and unseeded scaffolds. 2-week-old cell-GelMA constructs were implanted into surgically created meniscus defects in an explant organ culture model. No cytotoxic effects were observed 3 weeks after implantation, and cells grew and aligned to the patterned GelMA strands. Gene expression profiles and histology indicated promotion of a fibrocartilage-like meniscus phenotype, and scaffold integration with repair tissue was observed in the explant model. We show that micropatterned GelMA scaffolds are non-toxic, produce organized cellular alignment, and promote meniscus-like tissue formation. Prefabrication of GelMA scaffolds with architectures mimicking the meniscus collagen bundle organization shows promise for meniscal repair. Furthermore, the technique presented may be scaled up to repair larger defects.
Introduction
The meniscus has a role in stabilizing the knee joint and functions as a shock absorber which protects articular cartilage during walking and sporting activities. A meniscal tear is the most frequently recorded orthopedic diagnosis, and partial or total meniscectomy remains the most common orthopedic procedure [1] . The annual incidence of meniscal injuries in the USA is estimated to be between 600,000 and 850,000, with 90% resulting in meniscal surgery. The vast majority of these procedures involve partial, sub-total or total meniscectomy [2] [3] [4] . Untreated damaged or degenerate meniscus can lead to the development of osteoarthritis (OA). OA is the main cause of disability in the USA, affecting over 27,000,000 people [5] . Despite substantial developments in surgical techniques, instrumentation, and orthopedic devices, long-term clinical outcomes are unsatisfactory.
Partial meniscectomy, in which only the torn and damaged portions of the menisci are removed [6] , is now the treatment of choice for meniscal tears that cannot be repaired. Partial meniscectomy effectively relieves the acute symptoms, such as pain, swelling, and locking of the knee. However, partial meniscectomy fails to prevent the onset of severe OA, which occurs on average 14 years after the original procedure [7, 8] .
Surgical attempts to repair the torn tissues are ineffective in the avascular zone and are associated with a re-rupture rate of 30% even in the vascular zone [4] . Furthermore, repairs deemed successful in the short term do not mitigate long-term degenerative changes and the onset of OA. The sequelae of meniscal injury and the clinical outcomes of meniscectomy or repair are significantly worse in patients over the age of 40 [9] . Despite major advances in surgical techniques and biomedical device development, a meta-analysis of 42 clinical studies found no difference in the incidence of radiographic OA after meniscal repair compared with partial or total meniscectomy [8] .
To address this medical challenge an attempt to repair meniscus tears was the first logical step taken by many researchers. Biomaterials used to culture meniscus cells or stem cells for meniscus repair include bioresorbable collagen matrices [10] , which have been implanted in human patients with varied outcomes [11] [12] [13] . Fibrin alone or fibrin with added growth factors has been used to heal horizontal tears in human patients [14] . A recent report describes human meniscus cells seeded on a resorbable combination of polyglycolic acid (PGA) and hyaluronic acid in fibrin [15] . Polyurethane scaffolds possess sufficient mechanical properties with optimal interconnective macro-porosity to facilitate cell in-growth and differentiation [16] . Vicryl mesh scaffolds have also been used to repair bucket handle lesions in porcine meniscus [17] . A combination of human bone marrow-derived stem cells (hMSC) and a collagen scaffold was used in ovine meniscus explants showing promising integration [18] . Better integration was seen when the open/spongy scaffold structure was adjacent to the tissue. Devitalized meniscus has also been used to take advantage of the existing tissue architecture [19, 20] . Although using the natural tissue may seem more promising for meniscus tears, a mature tissue scaffold without cells may not be ideal, and the availability of mensiscal tissue is also an issue.
A cell-seeded supportive scaffold system that emulates the structure and possesses the mechanical properties of native meniscus may aid in integrating and stabilizing the repair site and promote seamless repair. In the short term such an implanted cellseeded scaffold should permit the cells to proliferate locally, migrate into the interface between the scaffold and native tissue, and secrete matrix components that integrate the scaffold.
Building structures mimicking native tissues can be accomplished using a number of nano-and micro-fabrication techniques, including melt molding, porogen leaching, gas foaming, phase separation, lamination, and fiber-based techniques [21] [22] [23] [24] [25] [26] . More recently rapid prototyping techniques have been applied to biomaterial scaffold fabrication to refine the spatial complexity with which complex three-dimensional (3-D) physiological architectures can be replicated in vitro using laser ablation, microfluidics and 3-D printing [21, [27] [28] [29] . In particular, projection stereolithography (PSL) or digital micromirror device (DMD) microfabrication, which uses an array of digitally controlled micromirrors to fabricate 3-D scaffolds layer by layer via a reflective photomask, is a promising technique. Because photomasks can be easily changed on demand the PSL approach is attractive due to its relative speed and flexibility compared with other photopatterning techniques [27, [30] [31] [32] [33] [34] . This technique allows the rapid assembly of cell-responsive hydrogels that feature highly specified complex 3-D geometries with micrometer resolution.
In this study we demonstrate the feasibility of combining cell therapy, photocrosslinkable hydrogels, and digital micromirror device projection stereolithography (DMD PSL) microfabrication to produce graft tissue for implantation and integration into a meniscus tear. We fabricated scaffolds using a hydrolyzed form of collagen type I, the major structural component of the meniscal tissue, to provide structure and function similar to the surrounding native meniscus tissue. We confirmed cell compatibility (viability), observed cell interactions with the patterned scaffold (attachment and organization), characterized the mechanical properties of the scaffold before and after cell seeding, demonstrated new human meniscus tissue formation, and explored the potential for cell-seeded GelMA scaffolds to integrate with native meniscus tissue in an ex vivo human meniscus defect.
Methods

Tissue procurement
Normal human meniscus (medial and lateral) was obtained from tissue banks (approved by Scripps institutional review board), from six donors (age range 18-61 years, mean age 37.2 ± 17.5, one female, five males). A previously reported macroscopic and histologic grading system was used to select normal menisci [35] .
Cell isolation and monolayer culture
Meniscus tissue was cut to isolate the avascular (inner two thirds) and vascular (outer one third) regions. The separated tissues were subjected to collagenase digestion as previously described [36] , except that digestion over 5-6 h. The digested tissues were filtered through 100 lm cell strainers (BD Biosciences, San Jose, CA) and seeded in monolayer culture in Dulbecco's modified Eagle's medium (DMEM) (Mediatech Inc., Manassas, VA) supplemented with 10% calf serum (Omega Scientific Inc., Tarzana, CA) and penicillin/streptomycin/gentamycin (Invitrogen, Carlsbad, CA).
Synthesis of methacrylated gelatin incorporating CaCO 3 particles (GelMA)
Gelatin methacrylate was prepared as described previously [37] . Briefly, porcine skin gelatin (Sigma-Aldrich, St Louis, MO) was dissolved at 10% w/v in phosphate-buffered saline (PBS) (Gibco/Life Technologies, Grand Island, NY) at 60°C and stirred for 1 h. Methacrylic anhydride (Sigma-Aldrich) was added at a rate of 0.5 ml min À1 at 50°C to achieve a final concentration of 7.5 vol.% and allowed to react for 2 h. The product was dialyzed against dH 2 O at 40°C for 1 week using dialysis tubing (molecular weight cut-off 12-14 kDa, Spectrum Laboratories). Finally, the solution was filtered (0.2 lm), frozen overnight (À80°C), and lyophilized for 1 week. The final product was stored at À80°C until further preparation.
To aid mechanical stability during fabrication CaCO 3 particles were incorporated into the final GelMA macromer solution. First, a 3% w/v macromer solution was prepared by adding GelMA to pre-warmed PBS (60°C) and stirring until fully dissolved. An equal volume of 1.65 M CaCl 2 in PBS was added to the GelMA solution until thoroughly mixed. 1.65 M Na 2 CO 3 in PBS (volume equivalent to the CaCl 2 solution) was added dropwise, and the mixture was stirred at 40°C for 24 h. After allowing the mixture to settle, excess supernatant was removed to produce a 1.5% w/v GelMA concentration. Additional GelMA was then added to reach a 15% w/v concentration. Photoinitiator Irgacure 2959 (1% w/v, Ciba/BASF, Florham Park, NJ), UV absorber 2-hydroxy-4-methoxy-benzphenone-5-sulfonic acid (0.1% w/v), and UV quencher TEMPO (0.01% w/v, Sigma-Aldrich) were added sequentially until fully dissolved.
To determine the extent of methacrylate conversion (i.e. the degree of modification of e-amine groups on lysines in gelatin), the 2,4,6-trinitrobenzenesulfonic acid solution (TNBS) assay as described by Habeeb was used [38] . The percentage amine substitution was calculated using the formula:
Percentage substitution ¼ ½1 À ðabsorbance of the methacrylated protein À absorbance of the blankÞ=ðabsorbance of the native protein À absorbance of the blankÞ Â 100%:
Digital micromirror device (DMD) projection stereolithography system
GelMA scaffolds were fabricated using a modified version of a DMD projection stereolithography (PSL) system described elsewhere [33] . The fabrication platform (Fig. 1A ) comprises a DMD system (1920 Â 1080 Discovery 4000, Texas Instruments), a servo-controlled stage (CMA-25-CCCL & ESP300, Newport), a UV light source (200 W, S2000, EXFO), a UV grade projection lens (Edmond Optics), and a replaceable glass coverslip window (No. 1, 22 Â 22 mm, Fisher) onto which the UV light is focused. Using a computer, specified patterns for each layer of the scaffold are loaded onto the DMD, which consists of a 1920 Â 1080 pixel array of micro-mirrors. These patterns provide a series of reflective photomasks that can be changed on demand. During fabrication UV light is reflected off the DMD and focused via the projection lens onto the photocurable GelMA solution, which is placed between the glass coverslip and the servo-controlled stage. The GelMA solution is selectively cured in the regions specified by the DMD array, with the height of each cured layer defined by the distance between the glass coverslip and the servo-controlled stage. The glass coverslip is coated with Krytox 157 FSH oil (DuPont, Wilmington, DE) to aid in release of the polymerized scaffold layer from the coverslip surface after UV exposure. The glass coverslip is replaced after fabrication of each layer. 
Layer by layer scaffold fabrication
Fig . 1A shows the scaffold fabrication process. The photocurable GelMA/CaCO 3 mixture was stirred at 35°C during fabrication. CaCO 3 aids in maintaining better structural integrity of the scaffold structure during fabrication and is removed after fabrication. After placing a drop of the GelMA/CaCO 3 on the stage the distance between the glass coverslip and the stage was adjusted initially to 100 lm for fabrication of the first layer. The UV image was then projected onto the glass coverslip for 8 s at a power of 50 mW cm À2 . After polymerization of the first layer the stage was moved down to release the scaffold from the glass coverslip. The scaffold and stage were washed with PBS, a new drop of Gel-MA/CaCO 3 was added to the top of the scaffold, and the coated glass coverslip was replaced. After changing the DMD image the stage was moved to the new position (100 lm), and the next layer was exposed to UV light. These steps were repeated for all five layers of the scaffold to construct the final layered 3-D structure approximately 500 lm high. Each longitudinal rod is 20 lm wide and $1800 lm long. These dimensions were chosen to represent the bundles of collagen fibrils that run circumferentially in the main central portion of the meniscus. The spacing between the rods (100 lm) was at the lower end of the pore diameter required for cellular infiltration. The supporting transverse rods are 50 lm wide and $1730 lm long. These were constructed to provide stability and link the longitudinal layers. The distance between the glass coverslip and the stage was increased for each subsequent layer by increments of 100 lm, and the images were projected using the same intensity and duration as the initial layer. Fig. 1A illustrates the specific image sequences used to generate the layered scaffold resembling a ''log pile'' to replicate the dominant structure of the circumferentially oriented collagen fibers in native menisci.
After fabrication the complete scaffold was removed from the stage using a scalpel, placed in a bath of 10 mM HCl for 30 min to dissolve the incorporated CaCO 3 , and thoroughly rinsed with PBS. In total the fabrication time for each five layer scaffold was approximately 35-40 min, including scaffold projection, washing and removal of the CaCO 3 .
Cell seeding and 3-D culture
The GelMA scaffolds were placed in cell culture inserts (8 lm, BD Biosciences) inserted into 24-well plates and maintained in PBS until ready for cell seeding. To seed the cells the PBS was removed and the cells were seeded at a density of 1 Â 10 6 cells ml À1 in 50 ll of medium (50,000 cells per scaffold). The 50 ll cell suspension remained on the scaffold for 20 min to permit cell attachment before medium was added to the outer well. The medium moved up through the membrane at the base of the cell culture insert to bathe the cell-seeded scaffold. However, higher volumes of medium were avoided since many scaffolds floated, which may reduce cell migration into the scaffold from the surrounding membrane.
The medium used in 3-D culture consisted of DMEM (Cellgro, Manassas, VA), 1 Â ITS + (Sigma) (i.e. 10 mg ml À1 insulin, 5.5 mg ml À1 transferrin, 5 ng ml À1 selenium, 0.5 mg ml À1 bovine serum albumin, 4.7 mg ml À1 linoleic acid), 1.25 mg ml À1 human serum albumin (Bayer, Leverkusen, Germany), 100 nM dexamethasone (Sigma), 0.1 mM ascorbic acid 2-phosphate (Sigma), and penicillin/streptomycin/gentamycin (Gibco, Carlsbad, CA) [39] .
This mix was filter sterilized through a 0.22 lm filter. To stimulate new meniscus tissue formation transforming growth factor (TGF) b1 (10 ng ml À1 ) was added to the medium immediately prior to use for all conditions.
Cell viability
The viability of cells cultured on GelMA scaffolds was observed using a live/dead kit consisting of calcein-AM and ethidium homerdimer-1 (Invitrogen) and a confocal laser microscope (LSM-510, Zeiss, Jena, Germany) as previously demonstrated [40] .
Histology and immunohistochemistry
2-week-old GelMA scaffolds seeded with meniscus fibrochondrocytes were cryofixed in tissue Tech (Info) on dry ice and cryosectioned at $7 lm thick. The sections were stained with hematoxylin and eosin (H&E) and safranin O-fast green. To detect collagen type I by immunohistochemistry cut sections were fixed in 4% formaldehyde for 10 min at room temperature, treated with hyaluronidase for 2 h [41] and incubated with primary antibodies against collagen type I (clone I-8H5, MP Biomedicals, Santa Ana, CA) at 10 lg ml
À1
. Secondary antibody staining and detection procedures were as previously described [42] . Isotype controls were used to control for non-specific staining.
RNA isolation and RT polymerase chain reaction (PCR)
Total RNA was isolated from the GelMA constructs using a RNAeasy mini kit (Qiagen, Hilden, Germany) and first strand cDNA was produced according to the manufacturer's protocols (Applied Biosystems, Foster City, CA). Quantitative RT-PCR was performed using TaqMan Ò gene expression reagents. COL1A1, aggrecan, Sox9 and GAPDH were detected using Assays-on-Demand™ primer/probe sets (Applied Biosystems). GAPDH was used to normalize gene expression levels using the recommended DC t method, and fold-change was calculated using the 2 ÀDDCt formula [43] .
Mechanical testing
The tensile strength of the GelMA construct along the axis of the ''log piles'' was assessed using a custom built device consisting of two miniature brushless servo actuators (SMAC, Carlsbad, CA) and one 50 g load cell (FUTEK, Irvine, CA). The scaffold was secured between two coverslips (100 lm thick) using a cyanoacrylate glue.
The base coverslip was glued down to a stainless steel block as an anchor, while the upper coverslip was attached to a steel plunger having a flat surface which served as the actuator to pull the scaffolds ( Supplementary Fig. 1 ). LabVIEW (National Instruments, Austin, TX) software was employed for movement control and data acquisition on a laptop. The gel height was measured using electronic calipers. The force to pull the gel to breaking was monitored and recorded. The Young's modulus was calculated as previously reported [44] .
Scanning electron microscopy (SEM)
Avascular meniscus cells cultured on GelMA for 14 days were washed with PBS and fixed with 2.5% w/v glutaraldehyde (Sigma, USA) for 1 h. After fixation they were washed three times with PBS for 10 min each wash. The scaffold was dehydrated in a graded series of ethanol (50%, 70%, and 90%) for 30 min each and left in 100% ethanol for 24 h at À20°C. The scaffold was dried in a critical point dryer (EMS 850, Electron Microscopy Science Co., Chelmsford, MA) and then surface metalized by sputter coating with iridium for SEM examination (XL30, FEI Co., Hillsboro, OR).
Organ culture repair model
Sections of human meniscus from one donor (18-year-old male) were cultured in medium in 6-well plates for 2-3 days following processing. One full thickness defect per tissue section was created with a scalpel parallel to the circumferential direction to simulate a longitudinal tear. Two-week-old cultured GelMA scaffolds with avascular meniscus fibrochondrocytes (22-year-old male) was placed in the defect with the ''log piles'' oriented parallel to the circumferential collagen bands. The tissues were maintained in differentiation medium (8 ml well
À1
) for 3 weeks (with medium changes every 2-3 days) and processed for histology to examine scaffold/cell integration with the native tissue and for new tissue development.
Results
Human meniscus cells are organized by the GelMA scaffold architecture
Following 2 weeks culture human avascular meniscus cells seeded onto GelMA scaffolds remained viable and were aligned along the ''log pile'' strands of GelMA (Fig. 2B and C) . Scanning electron micrographs showed the alignment and intimate interaction between the meniscus cells and GelMA scaffold (Fig. 2D-E) .
Meniscus-like new tissue is formed on GelMA scaffolds
The Young's modulus of the scaffold was 14.3 ± 4.0 kPa (Fig. 3) . No change in mechanical properties was detected over time in culture medium alone or when seeded with cells (Fig. 3) . The extent of methacrylation was calculated to be greater than 90%, with a mass swelling ratio of 5.9, indicating that the mechanical properties of the GelMA were close to maximum [45] . Histological analysis indicated the formation of multilayered and aligned new tissue ( Fig. 4A-E) . This tissue lacked glycosaminoglycans (GAG), as seen in the safranin-O staining (Fig. 4D ), yet contained collagen type I (Fig. 4E) , which complements the gene expression profile of high COL1A1 mRNA levels (Fig. 4F) . Increased Sox9 also indicates redifferentiation to the meniscus phenotype (data shown as gene expression relative to monolayer cultured cells).
Cell seeded GelMA scaffolds integrate with native meniscus tissue
Human meniscus cells seeded on GelMA scaffolds for 2 weeks were placed in surgically created defects in meniscus tissue (Fig. 5A and B) . After 3 weeks of free swelling culture in 6-well plates histological analysis revealed the generation of new tissue between the implanted scaffolds and the native tissue (Fig. 5C-N) . The new tissue is multilayered (Fig. 5D ) and shows virtually no GAG staining (Fig. 5G) .
Discussion
Digital micromirror device projection stereolithography (DMD PSL) to produce specified micropatterns is a useful means to create scaffolds that emulate the structure of native tissue architectures. We have shown that the micropatterned GelMA scaffolds produced in this study maintain human meniscus cell viability without cytotoxic effects, produce an organized cellular alignment in response to the scaffold microstructure, and promote the formation of meniscus-like tissues. Prefabrication of organized GelMA scaffolds with an architecture mimicking the meniscus collagen bundle organization shows promise for the repair of meniscal tears, as demonstrated by the formation of integrated new tissue in the ex vivo meniscus defect model. Scaling up of this approach may be useful to repair larger defects.
To our knowledge scaffolds employing DMD microfabrication have not been used for meniscus tissue engineering nor for meniscal defect repair. Specific combinations of GelMA and microengineering have been tested with various cell types and to direct specific cell patterns, including fibroblasts, myoblasts, endothelial cells, cardiac stem cells [37] , human umbilical vein endothelial cells [46] , NIH-3T3 cells and human mesenchymal stem cells [47] . Spatial organization of embryoid bodies have been made in GelMA [48] and Aubin et al. [37] demonstrated that GelMA hydrogels could be useful in creating complex, cell-responsive microtissues, such as endothelialized microvasculature. Other studies using projection printing technologies have been used with numerous different cell types [1, 31, 34, 49, 50] . Combined application of GelMA hydrogels and dielectrophoresis (DEP) is another method for creating highly complex microscale scaffold/tissue constructs using myoblasts or endothelial cells [47] .
The new tissue produced on the GelMA scaffolds appeared to be fibrocartilage-like with high expression of COL1A1 (mRNA and protein), as reported elsewhere for native [51] [52] [53] [54] and engineered meniscus [15] . Similarly to the vascular region, we did not observe increased aggrecan expression or detect COL2A1. The increase in Sox9 expression indicates that longer term cultures may be needed to induce expression of COL2A1 and aggrecan [55] . Mechanical stimulation [27, 56, 57] , hypoxic conditions [58, 59] , or other growth factors such as TGFb3 [60, 61] , insulin-like growth factor 1 [62] and fibroblast growth factor 2 [62, 63] might perhaps enhance tissue generation relative to the non-mechanical loading, normoxic conditions and TGFb1 used in this current study. Sox9 expression may also indicate the beginning of a shift towards a more ''chondrocyte-like'' phenotype that is characteristic of the avascular region [64] [65] [66] .
The in vitro model developed here has demonstrated the potential for cell-seeded GelMA to integrate with native tissues. The open structure of the GelMA scaffold mimicking native collagen fiber bundles may also have encouraged integration. Pabbruwe et al. [18] seeded MSC in collagen scaffolds which they implanted into ovine meniscus explants. Better integration was seen with scaffolds when the open/spongy structure was adjacent to the tissue. As discussed, the new tissue formed on GelMA may be more reminiscent of repair in the vascular zone of meniscus. Vascular zone tissue transplanted into avascular zone defects was shown to better integrate with the surrounding avascular tissue compared with re-implanted avascular zone tissue [50] . Combining GelMA with other biocompatible materials, like fibrin glue, may further promote defect repair. Synovial tissue grafts were implanted into human meniscal lesions and were found to integrate better compared with fibrin glue in terms of cell infiltration and improved tissue formation in the defect [67] . Therefore synoviocytes might be useful as they are more readily available than meniscal cells.
The use of a DMD PSL system allowed the formation of 3-D Gel-MA scaffolds with aligned gelatin fibers mimicking the collagen bundles of native meniscal tissue. In contrast to other 3-D patterning approaches, DMD projection printing offers advantages in terms of speed, flexibility, and scalability. Generally the use of photopolymer-based approaches allows the production of complex patterns that may be difficult to construct using cast molding and electrospinning. While 3-D plotting can fabricate sophisticated architectures, the approach is often limited by its slow processing speed and the low mechanical strength of the final scaffolds [21] . Micromirror arrays allow the use of rapidly interchangeable photomasks during the layer by layer fabrication process, providing more rapid construction of the patterned substrates. This ability to generate a complete layer in one simultaneous exposure confers improved scalability to the PSL platform. Additionally, as each layer is created in a discrete step with replenishment of the prepolymer, a multilayered composite 3-D structure can be easily created by exchanging the prepolymer composition at various points. The projection printing method is limited mainly by its lower resolution ($5 lm) compared with two photon polymerization methods, as well as by post-curing steps that may be necessary to provide additional mechanical integrity. Because polymerization of each additional layer further irradiates the preceding layers, cumulative exposure and thereby crosslinking density may vary throughout the layers if the prepolymer solution is not properly rinsed out and replenished for each step. Additionally, not all biopolymers may be amenable to the modifications necessary to make them photopolymerizable [15] .
Despite the favorable interaction of human meniscus cells with the GelMA scaffolds (low toxicity and new tissue formation), we noted a number of less favorable outcomes. Promising integration between the new tissue and the native meniscus tissue was observed in an ex vivo defect model, however, the relatively poor tensile mechanical properties of the existing GelMA scaffolds may not withstand the mechanical forces in the in vivo knee environment. The stiffness of the DMD fabricated scaffold was lower than reported for solid GelMA, reflecting the effect of the spaces between the ''logs'' [45] . The stiffness to withstand clinically relevant forces is much higher ($150 kPA) and not likely to be achievable with GelMA [68] . To overcome this variable other hydrogels possessing tunable mechanical properties, such as polyethylene glycol [30, 49, 69] or alginate [27] , could be used employing a DMD PSL system. We also noted an issue with uniform cell seeding. The majority of seeded cells remained on the surface of the GelMA construct. While using the projected printing technologies described here it would be conceivable to accurately incorporate a chemoattractant molecule, like platelet-derived growth factor [70] into the internal layers of the scaffold to encourage better scaffold cell infiltration.
Conclusions
In summary, we have demonstrated the utility of using DMD PSL with GelMA for the rapid production of organized scaffolds that emulate meniscus collagen bundles, which directed cell alignment and supported the development of viable new meniscus tissue in vitro. Moreover, we have shown the promise of using these scaffolds to repair meniscus lesions in an ex vivo organ culture model. Scaling up of this approach may be useful to repair larger defects.
